Evidence map›Paper›PMID 30787070›Full record

ArticleDiabetes2019

Leveraging Genetics to Improve Cardiovascular Health in Diabetes: The 2018 Edwin Bierman Award Lecture.

Alessandro Doria

Open access · hybridAbstract read
In one paragraph

Article in Diabetes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.5field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Alessandro DoriaResearch Division, Joslin Diabetes Center, Boston, MA alessandro.doria@joslin.harvard.edu.ORCID 0000-0002-3830-4304
Joslin Diabetes Center · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI JEAN E. SCHAFFER · 1986 to 2026
$50.5M
Variability in Adipokine Genes and AtherosclerosisR01HL073168 · NHLBI · JOSLIN DIABETES CENTER · PI DORIA, ALESSANDRO · 2003 to 2012
$5.8M
Genetic Markers of CHD in Type 2 DiabetesR01HL071981 · NHLBI · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI QI, LU · 2003 to 2012
$4.9M
Genetic modifiers of the effect of intensive glycemic control on CVD riskR01HL110400 · NHLBI · JOSLIN DIABETES CENTER · PI DORIA, ALESSANDRO · 2011 to 2014
$3.8M
An Exome-Focused Approach to Pharmacogenetic Analysis of the ACCORD TrialR01HL110380 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, WAGNER, MICHAEL JAY · 2012 to 2015
$2.4M
NHLBI NIH HHS R01 HL071981NHLBI NIH HHS R01 HL073168NHLBI NIH HHS R01 HL110380NHLBI NIH HHS R01 HL110400NIDDK NIH HHS P30 DK036836
6 · The paper itself

Abstract

The past decade has witnessed an exponential increase in our ability to search the genome for genetic factors predisposing to cardiovascular disease (CVD) and in particular coronary heart disease (CHD). Identifying these genes could lead to the development of innovative strategies to prevent the cardiovascular complications of diabetes by allowing us to

Indexed as

AlgorithmsAnimalsCardiovascular DiseasesCoronary DiseaseDiabetes MellitusGenetic Predisposition to DiseaseHumans

Identifiers

PMID30787070
PMCPMC6385753
OpenAlexW2917107774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.